Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AEMD vs $NMTC | Chartloom

Compare

$AEMD vs $NMTC

Aethlon Medical Inc · NeuroOne Medical Technologies Corp

AEMD

Aethlon Medical Inc

NMTC

NeuroOne Medical Technologies Corp

Compare $AEMD vs $NMTC

Comparing Aethlon Medical Inc and NeuroOne Medical Technologies Corp

AEMDAethlon Medical Inc

NMTCNeuroOne Medical Technologies Corp

AEMDAethlon Medical Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

96.5%

YTD performance

-60.4%

52W performance

-83.9%

FCF yield

-49.0%

NMTCNeuroOne Medical Technologies Corp

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.76x

Rev growth (TTM)

3.8%

YTD performance

-78.5%

52W performance

-80.7%

FCF yield

-74.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AEMD

NMTC

Detailed metrics comparison

AEMD

Aethlon Medical Inc

NMTC

NeuroOne Medical Technologies Corp

Market Cap

AEMD$15M

NMTC$10M

Enterprise Value

AEMD$10M

NMTC$8M

Price

AEMD$5.58

NMTC$1.10

P/E Ratio

AEMDN/A

NMTCN/A

P/S Ratio

AEMD17.03x

NMTC0.96x

EV/Sales

AEMD8.37x

NMTC0.75x

EV/EBITDA

AEMD0.00x

NMTC0.00x

P/B Ratio

AEMD1.87x

NMTC2.71x

P/FCF Ratio

AEMDN/A

NMTCN/A

EV/FCF

AEMD-1.35x

NMTC-1.05x

PEG Ratio

AEMDN/A

NMTCN/A

Forward P/E (NTM)

AEMDN/A

NMTCN/A

Forward P/S (NTM)

AEMDN/A

NMTC0.76x

Revenue (TTM)

AEMD$0

NMTC$10M

Revenue Growth (YoY)

AEMD96.5%

NMTC3.8%

Forward Rev Growth

AEMD170.9%

NMTC57.3%

Gross Margin (TTM)

AEMD0.0%

NMTC55.7%

Operating Margin (TTM)

AEMD0.0%

NMTC0.0%

EBITDA Margin (TTM)

AEMD0.0%

NMTC-73.7%

Net Margin (TTM)

AEMD0.0%

NMTC-71.5%

FCF Margin (TTM)

AEMDN/A

NMTC-71.6%

Net Income (TTM)

AEMD$-7M

NMTC$-7M

FCF (TTM)

AEMD$-7M

NMTC$-7M

EPS (TTM)

AEMD-$18.03

NMTC-$0.83

ROE (TTM)

AEMD-12309.0%

NMTC-12645.0%

ROA (TTM)

AEMD-9929.0%

NMTC-8558.0%

ROIC (TTM)

AEMD-12309.0%

NMTC-12645.0%

Cash

AEMD$5M

NMTC$2M

Debt

AEMD$0

NMTC$0

Net Cash/Debt

AEMD$5M

NMTC$2M

Current Ratio (TTM)

AEMD5.42x

NMTC2.84x

Quick Ratio (TTM)

AEMD5.14x

NMTC1.56x

Debt/Equity (TTM)

AEMD0.00x

NMTC0.00x

Debt/Assets (TTM)

AEMD0.0%

NMTC0.0%

Interest Coverage (TTM)

AEMDN/A

NMTCN/A

Net Debt/EBITDA (TTM)

AEMD0.00x

NMTC0.00x

Beta

AEMD1.20

NMTC0.92

52W Performance

AEMD-83.9%

NMTC-80.7%

YTD Performance

AEMD-60.4%

NMTC-78.5%

% from 52W High

AEMD-84.5%

NMTC-82.0%

% from 52W Low

AEMD295.7%

NMTC14.4%

Asset Turnover (TTM)

AEMD0.03x

NMTC1.20x

FCF Yield (TTM)

AEMD-49.0%

NMTC-74.8%

Earnings Yield (TTM)

AEMD-47.3%

NMTC-74.7%

Dividend Yield (TTM)

AEMDN/A

NMTCN/A

Rule of 40

AEMD96.6

NMTC-67.8

EV/GP/RG

AEMDN/A

NMTC0.05

Ticker research

View AEMD research View NMTC research

Metric	AEMD Aethlon Medical Inc	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$15M	$10M
Enterprise Value	$10M	$8M
Price	$5.58	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	17.03x	0.96x
EV/Sales	8.37x	0.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	2.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.35x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.76x
Revenue & Growth
Revenue (TTM)	$0	$10M
Revenue Growth (YoY)	96.5%	3.8%
Forward Rev Growth	170.9%	57.3%
Profitability
Gross Margin (TTM)	0.0%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-73.7%
Net Margin (TTM)	0.0%	-71.5%
FCF Margin (TTM)	N/A	-71.6%
Net Income (TTM)	$-7M	$-7M
FCF (TTM)	$-7M	$-7M
EPS (TTM)	-$18.03	-$0.83
ROE (TTM)	-12309.0%	-12645.0%
ROA (TTM)	-9929.0%	-8558.0%
ROIC (TTM)	-12309.0%	-12645.0%
Financial Health
Cash	$5M	$2M
Debt	$0	$0
Net Cash/Debt	$5M	$2M
Current Ratio (TTM)	5.42x	2.84x
Quick Ratio (TTM)	5.14x	1.56x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	0.92
52W Performance	-83.9%	-80.7%
YTD Performance	-60.4%	-78.5%
% from 52W High	-84.5%	-82.0%
% from 52W Low	295.7%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	1.20x
FCF Yield (TTM)	-49.0%	-74.8%
Earnings Yield (TTM)	-47.3%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	96.6	-67.8
EV/GP/RG	N/A	0.05
Ticker research	View AEMD research	View NMTC research

Valuation

P/S Ratio

NMTC

0.96x

AEMD

17.03x

EV/FCF

AEMD

-1.35x

NMTC

-1.05x

Growth & revenue

Revenue Growth TTM

AEMD

96.5%

NMTC

3.8%

Forward Revenue Growth

AEMD

170.9%

NMTC

57.3%

Profitability & performance

Gross Margin

NMTC

55.7%

AEMD

0.0%

ROE

AEMD

-12309.0%

NMTC

-12645.0%

FCF Yield %

AEMD

-49.0%

NMTC

-74.8%

52-Week Performance

NMTC

-80.7%

AEMD

-83.9%

Detailed metrics comparison

AEMD

Aethlon Medical Inc

NMTC

NeuroOne Medical Technologies Corp

Market Cap

AEMD$15M

NMTC$10M

Enterprise Value

AEMD$10M

NMTC$8M

Price

AEMD$5.58

NMTC$1.10

P/E Ratio

AEMDN/A

NMTCN/A

P/S Ratio

AEMD17.03x

NMTC0.96x

EV/Sales

AEMD8.37x

NMTC0.75x

EV/EBITDA

AEMD0.00x

NMTC0.00x

P/B Ratio

AEMD1.87x

NMTC2.71x

P/FCF Ratio

AEMDN/A

NMTCN/A

EV/FCF

AEMD-1.35x

NMTC-1.05x

PEG Ratio

AEMDN/A

NMTCN/A

Forward P/E (NTM)

AEMDN/A

NMTCN/A

Forward P/S (NTM)

AEMDN/A

NMTC0.76x

Revenue (TTM)

AEMD$0

NMTC$10M

Revenue Growth (YoY)

AEMD96.5%

NMTC3.8%

Forward Rev Growth

AEMD170.9%

NMTC57.3%

Gross Margin (TTM)

AEMD0.0%

NMTC55.7%

Operating Margin (TTM)

AEMD0.0%

NMTC0.0%

EBITDA Margin (TTM)

AEMD0.0%

NMTC-73.7%

Net Margin (TTM)

AEMD0.0%

NMTC-71.5%

FCF Margin (TTM)

AEMDN/A

NMTC-71.6%

Net Income (TTM)

AEMD$-7M

NMTC$-7M

FCF (TTM)

AEMD$-7M

NMTC$-7M

EPS (TTM)

AEMD-$18.03

NMTC-$0.83

ROE (TTM)

AEMD-12309.0%

NMTC-12645.0%

ROA (TTM)

AEMD-9929.0%

NMTC-8558.0%

ROIC (TTM)

AEMD-12309.0%

NMTC-12645.0%

Cash

AEMD$5M

NMTC$2M

Debt

AEMD$0

NMTC$0

Net Cash/Debt

AEMD$5M

NMTC$2M

Current Ratio (TTM)

AEMD5.42x

NMTC2.84x

Quick Ratio (TTM)

AEMD5.14x

NMTC1.56x

Debt/Equity (TTM)

AEMD0.00x

NMTC0.00x

Debt/Assets (TTM)

AEMD0.0%

NMTC0.0%

Interest Coverage (TTM)

AEMDN/A

NMTCN/A

Net Debt/EBITDA (TTM)

AEMD0.00x

NMTC0.00x

Beta

AEMD1.20

NMTC0.92

52W Performance

AEMD-83.9%

NMTC-80.7%

YTD Performance

AEMD-60.4%

NMTC-78.5%

% from 52W High

AEMD-84.5%

NMTC-82.0%

% from 52W Low

AEMD295.7%

NMTC14.4%

Asset Turnover (TTM)

AEMD0.03x

NMTC1.20x

FCF Yield (TTM)

AEMD-49.0%

NMTC-74.8%

Earnings Yield (TTM)

AEMD-47.3%

NMTC-74.7%

Dividend Yield (TTM)

AEMDN/A

NMTCN/A

Rule of 40

AEMD96.6

NMTC-67.8

EV/GP/RG

AEMDN/A

NMTC0.05

Ticker research

View AEMD research View NMTC research

Metric	AEMD Aethlon Medical Inc	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$15M	$10M
Enterprise Value	$10M	$8M
Price	$5.58	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	17.03x	0.96x
EV/Sales	8.37x	0.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	2.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.35x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.76x
Revenue & Growth
Revenue (TTM)	$0	$10M
Revenue Growth (YoY)	96.5%	3.8%
Forward Rev Growth	170.9%	57.3%
Profitability
Gross Margin (TTM)	0.0%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-73.7%
Net Margin (TTM)	0.0%	-71.5%
FCF Margin (TTM)	N/A	-71.6%
Net Income (TTM)	$-7M	$-7M
FCF (TTM)	$-7M	$-7M
EPS (TTM)	-$18.03	-$0.83
ROE (TTM)	-12309.0%	-12645.0%
ROA (TTM)	-9929.0%	-8558.0%
ROIC (TTM)	-12309.0%	-12645.0%
Financial Health
Cash	$5M	$2M
Debt	$0	$0
Net Cash/Debt	$5M	$2M
Current Ratio (TTM)	5.42x	2.84x
Quick Ratio (TTM)	5.14x	1.56x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	0.92
52W Performance	-83.9%	-80.7%
YTD Performance	-60.4%	-78.5%
% from 52W High	-84.5%	-82.0%
% from 52W Low	295.7%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	1.20x
FCF Yield (TTM)	-49.0%	-74.8%
Earnings Yield (TTM)	-47.3%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	96.6	-67.8
EV/GP/RG	N/A	0.05
Ticker research	View AEMD research	View NMTC research